Breast Cancer

SAN ANTONIO — Futibatinib plus fulvestrant exhibited antitumor activity among certain patients with locally advanced or metastatic breast cancer with fibroblast growth factor receptor 1 amplification, according to study results.

Deteriorating quality of life for women with breast cancer was associated with many common modifiable psychosocial and lifestyle-related factors, according to an analysis published in JAMA Network Open.

A higher-than-expected percentage of women with breast cancer who underwent breast-conserving surgery underwent re-excision within a year, according to retrospective findings published in Annals of Surgical Oncology.

Arielle J. Medford, MD, is working diligently to further refine individualized treatment for patients with breast cancer with the use of circulating tumor DNA and genomics at large.

Women in Oncology, a first-of-its kind effort from Healio, will inform, inspire, engage and empower female professionals with guidance from those who have exceled in their professional careers, mentored younger doctors, and led full and rewarding personal lives.

Amy Comander, MD, DipABLM, was not born a runner.

The treatment landscape for metastatic breast cancer has evolved tremendously within the past 2 decades.

Multinational Association of Supportive Care in Cancer published the first set of consensus guidelines intended to prevent lymphedema among patients who underwent surgery for breast cancer.

U.S. policies built around racism and persistent discrimination impact modern-day breast cancer outcomes, with worse outcomes for women living in historically redlined areas, according to study findings published in JAMA Network Open.

Women with unmet social needs are significantly less likely to undergo breast cancer screening and to have later-stage cancer at diagnosis even when free mammography is available, according to study results published in JAMA Network Open.